Cardiac 7-transmembrane-spanning domain receptor portfolios: diversify, diversify, diversify
Open Access
- 23 March 2006
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (4) , 875-877
- https://doi.org/10.1172/JCI28234
Abstract
Enhanced signaling in myocytes by the G protein Gq has been implicated in cardiac hypertrophy and the transition to heart failure. α1-Adrenergic receptors (α1-ARs) are members of the 7-transmembrane-spanning domain (7-TM) receptor family and signal via interaction with Gq in the heart. The specific effects of a loss of α1-AR signaling in the heart are explored by O’Connell et al. in this issue of the JCI (see the related article beginning on page 1005). Paradoxically, gene ablation of the α1A and α1B subtypes in mice results in a maladaptive form of reactive cardiac hypertrophy from pressure overload, with a predisposition to heart failure. Thus signaling to the α1-AR (compared with signaling from other receptors such as angiotensin receptors, which also couple to Gq) appears to be specifically required for a normal hypertrophic response. This represents another example of how receptors that share common G proteins have diversified, developing unique signaling programs. These findings may have particular clinical relevance because of the widespread use of α1-AR antagonists in the treatment of hypertension and symptomatic prostate enlargement.This publication has 17 references indexed in Scilit:
- 1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overloadJournal of Clinical Investigation, 2006
- Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor ReceptorsMolecular Pharmacology, 2005
- Physiologic Growth and Pathologic Genes in Cardiac Development and CardiomyopathyTrends in Cardiovascular Medicine, 2005
- Physiological Growth Synergizes With Pathological Genes in Experimental CardiomyopathyCirculation Research, 2004
- Risk of Congestive Heart Failure in an Elderly Population Treated with Peripheral Alpha‐1 AntagonistsJournal of the American Geriatrics Society, 2004
- Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failureThe American Journal of Cardiology, 2000
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998
- Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing MiceCirculation, 1998
- Transgenic Gαq overexpression induces cardiac contractile failure in miceProceedings of the National Academy of Sciences, 1997
- Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy.Proceedings of the National Academy of Sciences, 1994